Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy
暂无分享，去创建一个
I. Weissman | A. Barkal | B. George | Kevin S. Kao | K. McKenna | A. Ring | Jonathan M. Tsai | R. Maute | K. Weiskopf | Layla J. Barkal | B. Rosental | J. Chen | P. Ho | Y. Y. Yiu | Nan G Ring | Maxim Markovic | S. Gordon | Robin Z Cheng | L. Barkal | N. G. Ring | Robin Z. Cheng